Glucosamine Supplementation Correlates With Reduced All-Cause Mortality
1st August 2020
Glucosamine is a polysaccharide that is found naturally in cartilaginous joint tissues, bones, skin, ligaments, and nails, and it is involved in protein and lipid synthesis. In the context of joints, synovial fluid contains glucosamine and occupies the space between joints, helping to reduce the friction of joint surfaces.
The evidence for its usefulness in addressing conditions such as arthritis is, however, small at best, though there is some data for its effectiveness as an anti-inflammatory, according to the results of a randomized clinical trial in 2015 [1].
However, glucosamine supplementation seems to correlate with lower all-cause mortality and other mortality risks, such as cardiovascular disease (CVD), cancer, respiratory and digestive diseases. A recent analysis published in the journal BMJ showed that glucosamine supplementation conveys around a 15% reduction of all-cause mortality [2]. This is a considerable amount when compared to other lifestyle interventions as well as other supplements. The data gathered is from a large number of people, and the trend of reduced mortality is unmistakable.